Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 1 - 25 of 3059 in total
Name Weight StructureDescriptionCategories
Gadoquatrane2579.05

C81H128Gd4N24O32
A low-dose tetrameric macrocyclic gadolinium-based contrast agent for contrast-enhanced MRI of CNS and body lesions in adults and children.Contrast Media / Diagnostic Uses of Chemicals / Drugs that are Mainly Renally Excreted / Gadolinium-based Contrast Agent / Lanthanoid Series Elements / Magnetic Resonance Contrast Activity / Magnetic Resonance Imaging Contrast Media / Metals, Rare Earth / Other Diagnostics / Paramagnetic Contrast Agent / Paramagnetic Contrast Media
Copper histidinate371.844

C12H16CuN6O4
A copper-histidine complex indicated as a replacement therapy for the treatment of Menkes disease to increase serum copper and ceruloplasmin levels.Mineral Supplements
Milsaperidone428.504

C24H29FN2O4
An atypical antipsychotic used to treat adults with schizophrenia and manic or mixed episodes associated with bipolar I disorder.Antidepressive Agents / Antidepressive Agents, Second-Generation / Antipsychotic Agents / Antipsychotic Agents (Second Generation [Atypical]) / Central Nervous System Depressants / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Serotonin 5-HT1 Receptor Antagonists / Serotonin 5-HT1A Receptor Antagonists / Serotonin 5-HT2 Receptor Antagonists / Serotonin 5-HT2A Receptor Antagonists / Serotonin 5-HT2C Receptor Antagonists / Serotonin Agents / Serotonin Receptor Antagonists
18F-PSMA-1007Not AnnotatedA fluorine-18-labeled PSMA-targeting diagnostic radiopharmaceutical indicated for PET imaging of PSMA-positive lesions in adults with persistent or biochemical recurrent prostate cancer.Amides / Amino Acids, Peptides, and Proteins / Benzene Derivatives / Diagnostic Radiopharmaceuticals / Fluorine Radioisotopes / Naphthalenes / Nicotinic Acids / Peptides / Positron Emitting Activity / Pyridines / Radioactive Diagnostic Agent / Tumour Detection
EnlicitideNot AvailableAn oral macrocyclic peptide PCSK9 inhibitor indicated as an adjunct to diet and exercise to reduce LDL-C in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia.Anticholesteremic Agents / Hypolipidemic Agents / Hypolipidemic Agents Indicated for Hyperlipidemia / Lipid Modifying Agents / Lipid Modifying Agents, Plain / Lipid Regulating Agents / Non-statin Hypolipidemic Agents Indicated for Hyperlipidemia / PCSK9 Inhibitor / Peptides, Cyclic / Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Inhibitors
Daraxonrasib811.06

C44H58N8O5S
An oral multi-selective RAS(ON) inhibitor indicated for previously treated metastatic pancreatic adenocarcinoma, acting through a cyclophilin A tri-complex to inhibit the active, GTP-bound state of mutant and wild-type RAS.Amides / Antineoplastic Agents / Antineoplastic Agents, Immunological / Cyclopropanes / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 CYP3A7 Substrates / Cytochrome P-450 Substrates / Hepatotoxic Agents / Indoles / P-glycoprotein inhibitors / P-glycoprotein substrates / Piperazines / Pyridazines / Pyridines / RAS GTPase Inhibitors / Thiazoles
Gozetotide947.005

C44H62N6O17
Not AnnotatedElements / Gallium / Gallium Isotopes / Isotopes / Metals / Metals, Heavy / Radioisotopes
Icotrokinra1898.19

C90H120N20O22S2
A macrocyclic peptide and oral interleukin-23 receptor antagonist peptide indicated for the treatment of moderate-to-severe plaque psoriasisAmino Acids, Peptides, and Proteins / Interleukin-23 Antagonist / Peptides
Oveporexton520.52

C23H25F5N2O4S
An oral orexin receptor 2 (OX2R)-selective agonist indicated for narcolepsy type 1 in adults, restoring deficient orexin signaling to promote wakefulness and reduce cataplexy and other REM-sleep-related symptoms.Biphenyl Compounds / BSEP/ABCB11 Inhibitors / Central Nervous System Agents / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Orexin receptor agonists / Pyrrolidines / Sulfonamides / Wakefulness-Promoting Agents
Sevabertinib484.94

C24H25ClN4O5
A HER2 kinase inhibitor used to treat non-squamous non-small cell lung cancer with HER2 (ERBB2) tyrosine kinase domain (TKD) activating mutations.Antineoplastic Agents / Tyrosine Kinase Inhibitors
Zidesamtinib419.464

C22H22FN7O
A brain-penetrant, ROS1-selective kinase inhibitor with activity against ROS1 resistance mutations, indicated for locally advanced or metastatic ROS1-positive NSCLC after a prior ROS1 kinase inhibitor.Aminopyridines / Anaplastic lymphoma kinase (ALK) inhibitors / Antineoplastic Agents / Antineoplastic and Immunomodulating Agents / BCRP/ABCG2 Inhibitors / Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 CYP3A7 Substrates / Cytochrome P-450 Substrates / Ethers, Cyclic / Kinase Inhibitor / MATE 1 Inhibitors / MATE inhibitors / P-glycoprotein inhibitors / Protein Kinase Inhibitors / Pyrazoles / Pyridines / QTc Prolonging Agents / ROS1 tyrosine kinase inhibitors / Triazoles / Tyrosine Kinase Inhibitors
Iopydone346.894

C5H3I2NO
Iopydone is a small molecule drug. Iopydone has a monoisotopic molecular weight of 346.83 Da.Pyridines / Pyridones
Tribromsalan449.924

C13H8Br3NO2
Tribromsalan is a small molecule drug. Tribromsalan has a monoisotopic molecular weight of 446.81 Da.Amides / Amines / Anilides / Aniline Compounds / Salicylamides
Dichlorotetrafluoroethane170.92

C2Cl2F4
Dichlorotetrafluoroethane is a small molecule drug. Dichlorotetrafluoroethane has a monoisotopic molecular weight of 169.93 Da.Chlorofluorocarbons / Hydrocarbons, Chlorinated / Hydrocarbons, Fluorinated / Hydrocarbons, Halogenated
Acetomenaphthone258.273

C15H14O4
Not AnnotatedNot Annotated
Pentapiperium304.453

C19H30NO2
Not AnnotatedNot Annotated
Benzoylpas257.245

C14H11NO4
Not AnnotatedNot Annotated
AZACYCLONOLNot AnnotatedNot AnnotatedNot Annotated
Parethoxycaine265.353

C15H23NO3
Parethoxycaine is a local anesthetic that was previously approved in the US.Not Annotated
Syrosingopine666.724

C35H42N2O11
Not AnnotatedAlkaloids / Antihypertensive Agents / Heterocyclic Compounds, Fused-Ring / Indole Alkaloids / Indoles / Indolizidines / Indolizines / Secologanin Tryptamine Alkaloids
Megestrol342.479

C22H30O3
Not AnnotatedAntineoplastic Agents, Hormonal / Contraceptives, Oral, Hormonal / Contraceptives, Oral, Synthetic / Pregnadien Derivatives / Progestogens and Estrogens, Sequential Preparations
SantoninNot AnnotatedSantonin is a anthelmintic drug that was previously approved in the US to treat certain parasitic infections.Antinematodal Agents
Salicylanilide213.236

C13H11NO2
Not AnnotatedAmides / Amines / Anilides / Aniline Compounds / Salicylamides
Chlorothymol184.66

C10H13ClO
Chlorotymol is a Thymol derivative.Not Annotated
OCTODRINE129.247

C8H19N
Not AnnotatedAlkanes / Hydrocarbons, Acyclic
Displaying drugs 1 - 25 of 3059 in total